Literature DB >> 8929757

Insight in schizophrenia and its relationship to psychopathology.

R A Kemp1, T J Lambert.   

Abstract

A group of 29 patients with DSM-IIIR schizophrenia was studied during acute hospital admission to examine the relationship between changes in insight and positive and negative symptomatology in schizophrenia. On admission, insight scores were obtained using a modification of the SUMD (Amador et al., 1993), and of the degree of psychopathology using the PANSS (Kay et al., 1987). These measures were repeated prior to discharge between 3 and 6 weeks later. Insight improved significantly during the course of in-patient treatment. A relationship between psychopathology and insight level was evident at both assessments, though the pattern was different. Improvement in psychopathology correlated significantly with increased insight into past symptoms but not current illness. When treatment responders were examined there was a significant relationship only with negative symptom improvement and PANSS totals, but not with improvement in positive symptoms. The greater the trend towards negative symptom predominance, the less the tendency to improve in the awareness of current symptoms. This study suggests an inverse relationship with enduring negative symptoms.

Entities:  

Mesh:

Year:  1995        PMID: 8929757     DOI: 10.1016/0920-9964(95)00018-6

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  19 in total

1.  Suicidal behavior and insight into illness among patients with schizophrenia spectrum disorders.

Authors:  Yu-Chen Kao; Yia-Ping Liu
Journal:  Psychiatr Q       Date:  2011-09

Review 2.  Correlates and long-term consequences of poor insight in patients with schizophrenia. A systematic review.

Authors:  Tania M Lincoln; Eva Lüllmann; Winfried Rief
Journal:  Schizophr Bull       Date:  2007-02-08       Impact factor: 9.306

3.  Subjective well-being, drug attitude, and changes in symptomatology in chronic schizophrenia patients starting treatment with new-generation antipsychotic medication.

Authors:  Christian G Widschwendter; Georg Kemmler; Maria A Rettenbacher; Nursen Yalcin-Siedentopf; Alex Hofer
Journal:  BMC Psychiatry       Date:  2018-06-28       Impact factor: 3.630

4.  [Insight and Violent Behavior in a Cohort of Early Psychosis Patients].

Authors:  Valerie Moulin; Julie Palix; Luis Alameda; M Mehdi Gholamrezaee; Philipp S Baumann; Jacques Gasser; Julien Elowe; Alessandra Solida; Philippe Conus
Journal:  Can J Psychiatry       Date:  2017-06-28       Impact factor: 4.356

Review 5.  Disorders of awareness in neuropsychiatric syndromes: an update.

Authors:  Laura A Flashman
Journal:  Curr Psychiatry Rep       Date:  2002-10       Impact factor: 5.285

6.  Call it a monster for lack of anything else: narrative insight in psychosis.

Authors:  David Roe; Ilanit Hasson-Ohayon; Shlomo Kravetz; Phil T Yanos; Paul H Lysaker
Journal:  J Nerv Ment Dis       Date:  2008-12       Impact factor: 2.254

7.  Effect of joint crisis plans on use of compulsory treatment in psychiatry: single blind randomised controlled trial.

Authors:  Claire Henderson; Chris Flood; Morven Leese; Graham Thornicroft; Kim Sutherby; George Szmukler
Journal:  BMJ       Date:  2004-07-07

8.  Insight in bipolar disorder: relationship to episode subtypes and symptom dimensions.

Authors:  Frederick Cassidy
Journal:  Neuropsychiatr Dis Treat       Date:  2010-10-05       Impact factor: 2.570

9.  Outcome of first-episode schizophrenia in India: longitudinal study of effect of insight and psychopathology.

Authors:  Balasubramanian Saravanan; K S Jacob; Shanthi Johnson; Martin Prince; Dinesh Bhugra; Anthony S David
Journal:  Br J Psychiatry       Date:  2010-06       Impact factor: 9.319

10.  Cross-sectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia.

Authors:  Somaia Mohamed; Robert Rosenheck; Joseph McEvoy; Marvin Swartz; Scott Stroup; Jeffrey A Lieberman
Journal:  Schizophr Bull       Date:  2008-06-26       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.